glp-1 drugs competitive intelligence 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Agonists Weight Loss Drugs
Description
These adverse reaction reports are self-reported by patients and their health-care providers, so they don't undergo review
One thing to settle before anything else
Available online: 21.No Data to Support Stopping GLP-1 Agonists Prior to Elective Endoscopy
Step #3
There was some evidence of asymmetry for MACE (Egger test, P = 0.059), suggesting a potential threat of publication bias
